Publications by authors named "Marita Ziepert"

49Publications

VEGFR2 and VEGFA polymorphism are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.

Eur J Haematol 2020 Sep 30. Epub 2020 Sep 30.

Department of Hematology and Oncology, Saarland University Medical School, Homburg (Saar), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13526DOI Listing
September 2020

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).

J Clin Oncol 2018 09 5;36(25):2593-2602. Epub 2018 Jul 5.

Qian Shi, Fang-Shu Ou, Jesse G. Dixon, and Thomas M. Habermann, Mayo Clinic, Rochester, MN; Norbert Schmitz, University of Muenster, Muenster; Michael Pfreundschuh, Universität des Saarlandes, Homburg; Marita Ziepert, University of Leipzig, Leipzig, Germany; David Cunningham, The Royal Marsden Hospital, Surrey, United Kingdom; John F. Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Ulrich Jaeger, Medical University of Vienna, Vienna, Austria; Corinne Haioun, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil; Hervé Tilly, Institut National de la Santé et de la Recherche Médicale U1245, Université de Rouen, Rouen; Hervé Ghesquieres and Bertrand Coiffier, Centre Hospitalier Lyon-Sud, Pierre-Benite; Raoul Herbrecht, Hôpital de Hautepierre, Strasbourg, France; Francesco Merli, Azienda Unità Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy; Jocelyne Flament, Celgene, Boudry, Switzerland; Tommy Fu, Celgene, Summit, NJ; and Christopher R. Flowers, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.9124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532366PMC
September 2018

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

J Clin Oncol 2017 Aug 19;35(22):2515-2526. Epub 2017 May 19.

Annette M. Staiger, Heike Horn, and German Ott, Institute of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart; Annette M. Staiger and Heike Horn, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; Annette M. Staiger and Heike Horn, University of Tuebingen, Tuebingen; Marita Ziepert and Markus Löffler, Institute for Medical Informatics, Statistics and Epidemiology, Universität Leipzig, Leipzig; Thomas F.E. Barth and Peter Möller, Institute of Pathology, Universitätsklinikum Ulm, Ulm; Heinz-Wolfram Bernd and Alfred C. Feller, Haematopathologie Luebeck, Luebeck; Wolfram Klapper and Monika Szczepanowski, Institute of Pathology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel; Monika Szczepanowski, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel; Michael Hummel and Dido Lenze, Institute of Pathology, Campus Benjamin Franklin, Charité Universitätsmedizin; Harald Stein, Pathodiagnostik Berlin, Berlin; Martin-Leo Hansmann and Sylvia Hartmann, Dr. Senckenberg Institute of Pathology, Goethe University Hospital, Frankfurt; Georg Lenz, Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, and Cluster of Excellence EXC 1003, Cells in Motion, Münster; Lorenz Trümper, Georg-August Universität, Göttingen; Norbert Schmitz, Asklepios Klinik St Georg, Hamburg; Michael Pfreundschuh, Saarland University Medical School, Homburg/Saar; Andreas Rosenwald, Institute of Pathology, Universität Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany; David W. Scott, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; and Sergio Cogliatti, Institute of Pathology, Kantonal Hospital St Gallen, St Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3660DOI Listing
August 2017

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

J Clin Oncol 2016 09 5;34(26):3150-6. Epub 2016 Jul 5.

Norbert Schmitz, Maike Nickelsen, and Bertram Glass, Asklepios Hospital St Georg, Hamburg; Samira Zeynalova, Marita Ziepert, and Markus Loeffler, University of Leipzig, Leipzig; Michael Pfreundschuh, Saarland University Medical School, Homburg, Germany; Roopesh Kansara, Diego Villa, Laurie H. Sehn, David W. Scott, Randy D. Gascoyne, Joseph M. Connors, and Kerry J. Savage, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.6520DOI Listing
September 2016

Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma.

Ann Hematol 2016 Jun 11;95(7):1121-8. Epub 2016 May 11.

Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St. Georg, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2671-5DOI Listing
June 2016

Histopathology of rhinophyma - a clinical-histopathologic correlation.

J Cutan Pathol 2015 Aug 4;42(8):527-35. Epub 2015 Jun 4.

Department of Dermatology, Venereology and Allergology, University Hospital of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12518DOI Listing
August 2015

Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab.

J Clin Oncol 2014 Oct 18;32(29):3242-8. Epub 2014 Aug 18.

Jörg Thomas Bittenbring, Frank Neumann, Marina Achenbach, Jörg Reichrath, Jürgen Geisel, Evi Regitz, Gerhard Held, and Michael Pfreundschuh, Klinik für Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg; and Bettina Altmann and Marita Ziepert, University Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.4537DOI Listing
October 2014

Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20(+) B-cell lymphomas.

Br J Haematol 2014 Nov 27;167(3):430-4. Epub 2014 Jun 27.

Department of Internal Medicine I, Oncology, Haematology, Clinical Immunology and Rheumatology, Saarland University Medical School, Homburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13001DOI Listing
November 2014

Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma.

Br J Haematol 2014 Aug 2;166(4):612-5. Epub 2014 Apr 2.

Department of Medicine V, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12877DOI Listing
August 2014

The role of myeloablation for lymphoma.

N Engl J Med 2014 02;370(6):574-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1314757DOI Listing
February 2014

Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma.

J Clin Oncol 2014 Apr 3;32(11):1112-8. Epub 2014 Feb 3.

Gerhard Held, Niels Murawski, Jochen Fleckenstein, Viola Pöschel, Carsten Zwick, Jörg Bittenbring, Jörg Schubert, Christian Rübe, and Michael Pfreundschuh, Universitätsklinikum des Saarlandes, Homburg; Marita Ziepert and Markus Löffler, Universität Leipzig, Leipzig; Mathias Hänel, Klinikum Chemnitz, Chemnitz; Sibylla Wilhelm, Städtisches Klinikum Karlsruhe, Karlsruhe; and Norbert Schmitz, Asklepios-Klinik St Georg, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4505DOI Listing
April 2014

Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement.

J Clin Oncol 2013 Nov 23;31(32):4115-22. Epub 2013 Sep 23.

Gerhard Held, Niels Murawski, Jochen Fleckenstein, Christian Rübe, and Michael Pfreundschuh, Saarland University Medical School; Bertram Glass and Norbert Schmitz, Asklepios-Klinik St. Georg, Hamburg; Samira Zeynalova and Marita Ziepert, Leipzig University, Leipzig; Barbara Kempf, Klinikum Landshut, Landshut; Andreas Viardot, Universitätsklinikum Ulm, Ulm; Martin Dreyling, Ludwig-Maximilian University, Munich; Michael Hallek, Cologne University, Cologne; and Mathias Witzens-Harig, Heidelberg University, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.0467DOI Listing
November 2013

KMWin--a convenient tool for graphical presentation of results from Kaplan-Meier survival time analysis.

PLoS One 2012 15;7(6):e38960. Epub 2012 Jun 15.

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038960PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376120PMC
December 2012

Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma.

Clin Cancer Res 2012 Jul 9;18(13):3637-47. Epub 2012 May 9.

Department of Hematology and Oncology, Medical Center of the Georg-August-University Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3299DOI Listing
July 2012

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

J Clin Oncol 2010 May 12;28(14):2373-80. Epub 2010 Apr 12.

Dipl-Math, Institute for Medical Informatics, Statistics, and Epidemiology, Universität Leipzig, Härtelstrasse 16-18, D-04107 Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.2493DOI Listing
May 2010

A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.

Cancer Res 2010 Mar 9;70(6):2328-38. Epub 2010 Mar 9.

Department of Clinical Pharmacology and Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-2388DOI Listing
March 2010